Agulo, Romelyn A.
HRN: 13-87-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2022
CEFUROXIME 1.5GM (VIAL)
11/25/2022
11/26/2022
IVT
1.5gms
Prior To OR
For EL USO Prophylaxis; Mature Cystic Ovarian Teratoma, Right
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes